MDS Virtual Congress 2021 Archives - Page 18 of 132

Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

B. Dorfman, M. Velickovic, W. Tse (New York, USA)
Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

C. Borrue, C. Jimeno (Madrid, Spain)
Brain activity of the emotional circuit in Parkinson’s disease patients with freezing of gait

E. Sarasso, F. Agosta, N. Piramide, E. Canu, MA. Volontè, M. Filippi (Milan, Italy)
Brain MRI Cortical Atrophy correlation to clinical onset in Huntington’s Disease

H. Estrada-Rodriguez, JD. Garcia-Romero, MA. Muñuzuri-Camacho, RA. Abundes-Corona, DD. Vásquez Guevara, LM. Gaibor Noboa, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico City, Mexico)
Brain MRI morphological changes in different self-reported sleep disturbances in PD patients

X. Ma, W. Su, H. Chen (Beijing, China)
Brain SPECT in Patients with Akinetic-Rigid Syndrome Secondary to Radiotherapy

C. Soldevila-Lozano, J. Mora-Salvadó, MT. Bajén-Lázaro, L. Rodríguez-Bel, L. Fernández-Romero, M. Cortés-Romera (Barcelona, Spain)
Brainstem planimetry in Parkinson’s disease with REM behaviour disorder.

D. Urso, S. Nigro, B. Tafuri, G. Logroscino (Tricase, Italy)
Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)

L. Ramig, R. Macdonald, P. Jiang, H. Hodges, J. Spielman, O. Reed, E. Nauman, C. Bergey, J. Cattiau (New York, USA)
Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group

J. Joubert, M. Tan, T. Antar, A. Martinez-Carrasco, H. Iwaki, H. Morris, GP2. Genetics Program (London, United Kingdom)
Burden of illness among US Medicare beneficiaries with late-onset Huntington’s disease

J. Ta, S. Reiss Reddy, E. Chang, A. Exuzides, R. Gandhy, G. Yohrling (South San Francisco, USA)